Case Control Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Oct 6, 2024; 12(28): 6165-6172
Published online Oct 6, 2024. doi: 10.12998/wjcc.v12.i28.6165
Table 1 Characteristics of patients

Treatment group (n = 58)
Control group (n = 52)
P value1
Gender (M/F)34/2432/200.5412
Age (year)63.3 ± 10.2265.4 ± 8.150.532
Duration of tinnitus (month)8.0 ± 5.48.2 ± 4.60.556
Hearing loss (yes/no)29/2130/200.1722
Sleep disturbance (yes/no)46/1243/100.0912
Poor dietary habits (yes/no)38/2034/180.3852
Spleen-stomach diseases (yes/no)48/1043/90.8912
TEQ13.56 ± 2.8812.78 ± 2.980.423
PSQI10.5 ± 5.2010.7 ± 4.820.361
DASS-21
    Depression10.17 ± 4.1011.22 ± 5.530.475
    Anxiety9.05 ± 3.669.78 ± 4.320.197
    Stress12.51 ± 6.3213.09 ± 5.760.061
Table 2 Changes in major variables of the measurements before and after 6 months of treatment
Treatment group (n = 58)
P value1
Control group (n = 52)
P value1
P value1
Pre-test
Post-test
Pre-test
Post-test
TEQ score13.56 ± 2.888.21 ± 2.540.02112.78 ± 2.9811.59 ± 3.770.0460.020
I6/5823/580.0085/5210/520.0120.042
II28/5817/580.02725/5223/520.570.003
III19/5813/580.04216/5214/520.0950.021
IV6/584/580.0465/524/520.3280.073
V2/581/580.0612/521/520.0550.65
PSQI total score10.95 ± 5.206.85 ± 4.560.04310.07 ± 4.8211.21 ± 6.340.9450.038
DASS-2131.12 ± 7.2324.87 ± 6.350.00332.21 ± 6.5928.32 ± 6.660.0430.032
Depression10.17 ± 4.108.32 ± 3.980.02711.22 ± 5.5310.56 ± 4.230.5430.045
Anxiety9.05 ± 3.667.21 ± 2.540.0119.78 ± 4.3210.11 ± 5.540.8420.019
Stress12.51 ± 6.3210.38 ± 4.780.04513.09 ± 5.7611.87 ± 4.650.0650.076